Today, NIIMBL (the National Institute for Innovation in Manufacturing Biopharmaceuticals) announced that a NIIMBL-led team will receive $10.5 Million in funding through the Gates Grand Challenges Program to advance exceptionally low-cost monoclonal antibody (mAb) manufacturing. Over the three-year award, key partners including Sartorius...
SMART USA has officially completed its Phase 1 startup—and what a launch it’s been. In just nine months, we’ve welcomed 100+ committed members, hosted a 350-person summit, and issued our first $50+ million project solicitation, which drew an exceptionally strong collaborative response from academics and industry across the country. These...
The REMADE Institute® , a 150+ member public-private partnership funded in part by the United States Department of Energy, today issued its seventh Request for Proposals, representing up to a $6 million investment in supplemental funding for technologies that support the nation's manufacturing competitiveness and supply chain resilience goals.
T...
The National Institute for Innovation in Manufacturing Biopharmaceuticals ( NIIMBL ) is pleased to announce awards for two projects to support Big Data Program initiatives on modeling and simulation. The awards stem from two Requests for Applications (RFAs) NIIMBL released in May 2025.
The 12-month projects are scheduled to begin in December.
The...
Today marks five years since BioMADE was announced as the bioindustrial Manufacturing Innovation Institute by the Department of Defense in October 2020. From our inception, BioMADE has championed innovation, collaboration, and resilience, growing into a national network of over 300 members and delivering transformative impact across industry...
